1. Home
  2. ROIV vs STLA Comparison

ROIV vs STLA Comparison

Compare ROIV & STLA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Roivant Sciences Ltd.

ROIV

Roivant Sciences Ltd.

HOLD

Current Price

$28.02

Market Cap

20.7B

Sector

Health Care

ML Signal

HOLD

Logo Stellantis N.V.

STLA

Stellantis N.V.

HOLD

Current Price

$7.17

Market Cap

19.4B

ML Signal

HOLD

Company Overview

Basic Information
Metric
ROIV
STLA
Founded
2014
2021
Country
United Kingdom
Netherlands
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Auto Manufacturing
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
20.7B
19.4B
IPO Year
2021
2014

Fundamental Metrics

Financial Performance
Metric
ROIV
STLA
Price
$28.02
$7.17
Analyst Decision
Strong Buy
Buy
Analyst Count
9
5
Target Price
$28.94
$11.59
AVG Volume (30 Days)
4.4M
17.8M
Earning Date
05-28-2026
02-26-2026
Dividend Yield
N/A
7.50%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$29,053,000.00
N/A
Revenue This Year
N/A
$7.18
Revenue Next Year
$744.61
$3.50
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$10.58
$6.28
52 Week High
$30.33
$12.22

Technical Indicators

Market Signals
Indicator
ROIV
STLA
Relative Strength Index (RSI) 48.61 36.31
Support Level $27.00 $7.07
Resistance Level $30.26 $10.31
Average True Range (ATR) 0.90 0.23
MACD -0.14 -0.14
Stochastic Oscillator 31.41 8.57

Price Performance

Historical Comparison
ROIV
STLA

About ROIV Roivant Sciences Ltd.

Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.

About STLA Stellantis N.V.

Stellantis was created out of the merger of US-based Fiat Chrysler Automobiles and French-based Peugeot in January 2021, resulting in the fourth-largest automotive original equipment manufacturer by vehicle sales. In 2024 it sold 5.5 million vehicles, 47%, 26% and 17% in Europe, North America, and South America, respectively. Its brands include Fiat, Jeep, Chrysler, Ram, Peugeot, Citroën, Opel, Alfa Romeo, and Maserati.

Share on Social Networks: